Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

15

Revenue 2017

Neulasta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Neulasta was produced by Amgen.

Neulasta rival from Teva cleared in EU

Neulasta rival from Teva cleared in EU Lonquex offers competition to Amgen drug in neutropaenia. Teva Pharmaceutical has been given a green light by the European Commission (EC) for Lonquex, a rival to Amgen's blockbuster Neulasta. ... Like Neulasta (pegfilgrastim), Lonquex is a long-acting

Onyx rejects $10bn takeover bid from Amgen

Onyx rejects $10bn takeover bid from Amgen back of declining sales for its anaemia products Epogen (epoetin alfa) and Aranesp (darbepoetin alfa) and white cell stimulators Neupogen (filgrastim) and Neulasta (pegfilgrastim).

Amgen forms joint venture in China to boost Vectibix

Amgen forms joint venture in China to boost Vectibix and its white blood cell stimulators Neulasta (pegfilgrastim) and Neupogen (filgrastim) are reaching maturity.

AP Pharma appoints Dendreon’s Jesse Hollingsworth to lead sales

AP Pharma appoints Dendreon’s Jesse Hollingsworth to lead sales This was preceded by a period as marketing director for the oncology business unit of Amgen, where he worked on such products as Neulasta, Neupogen and Vectibix.

Amgen profits down on rising costs

Amgen profits down on rising costs white cell stimulators Neupogen (filgrastim) and  Neulasta (pegfilgrastim). ... Combined sales of Neupogen and Neulasta were down 1 per cent to just over $1.3bn, thanks largely to competition from biosimilars in Europe.

[ Previous 5 results ] 1 2 3 4 5 6 7 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
certain health

Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....